152 related articles for article (PubMed ID: 22986435)
21. Autoantibodies in Pandemrix
Wallenius M; Lind A; Akel O; Karlsson E; Svensson M; Arvidsson E; Ramelius A; Törn C; Palm L; Lernmark Å; Elding Larsson H
Autoimmunity; 2019 Jun; 52(4):185-191. PubMed ID: 31328572
[No Abstract] [Full Text] [Related]
22. The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis.
Kaushansky N; Eisenstein M; Zilkha-Falb R; Ben-Nun A
Autoimmun Rev; 2010 Feb; 9(4):233-6. PubMed ID: 19683076
[TBL] [Abstract][Full Text] [Related]
23. Enhanced accumulation of Kir4.1 protein, but not mRNA, in a murine model of cuprizone-induced demyelination.
Nakajima M; Kawamura T; Tokui R; Furuta K; Sugino M; Nakanishi M; Okuyama S; Furukawa Y
Brain Res; 2013 Nov; 1537():340-9. PubMed ID: 24070676
[TBL] [Abstract][Full Text] [Related]
24. Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis.
Greer JM; Pender MP
J Autoimmun; 2008 Nov; 31(3):281-7. PubMed ID: 18502611
[TBL] [Abstract][Full Text] [Related]
25. Autoantigens and autoantibodies in multiple sclerosis.
Mirshafiey A; Kianiaslani M
Iran J Allergy Asthma Immunol; 2013 Aug; 12(4):292-303. PubMed ID: 23996705
[TBL] [Abstract][Full Text] [Related]
26. The initiation of the autoimmune response in multiple sclerosis.
Markovic-Plese S; Pinilla C; Martin R
Clin Neurol Neurosurg; 2004 Jun; 106(3):218-22. PubMed ID: 15177771
[TBL] [Abstract][Full Text] [Related]
27. Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis.
Belogurov AA; Kurkova IN; Friboulet A; Thomas D; Misikov VK; Zakharova MY; Suchkov SV; Kotov SV; Alehin AI; Avalle B; Souslova EA; Morse HC; Gabibov AG; Ponomarenko NA
J Immunol; 2008 Jan; 180(2):1258-67. PubMed ID: 18178866
[TBL] [Abstract][Full Text] [Related]
28. Autoreactivity to myelin antigens: myelin/oligodendrocyte glycoprotein is a prevalent autoantigen.
Diaz-Villoslada P; Shih A; Shao L; Genain CP; Hauser SL
J Neuroimmunol; 1999 Sep; 99(1):36-43. PubMed ID: 10496175
[TBL] [Abstract][Full Text] [Related]
29. Expression of Kir4.1 and Kir5.1 inwardly rectifying potassium channels in oligodendrocytes, the myelinating cells of the CNS.
Brasko C; Hawkins V; De La Rocha IC; Butt AM
Brain Struct Funct; 2017 Jan; 222(1):41-59. PubMed ID: 26879293
[TBL] [Abstract][Full Text] [Related]
30. The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
Lee DH; Linker RA
Expert Opin Ther Targets; 2012 May; 16(5):451-62. PubMed ID: 22494461
[TBL] [Abstract][Full Text] [Related]
31. MOG antibody-associated demyelinating disease mimicking typical multiple sclerosis: A case for expanding anti-MOG testing?
Breza M; Koutsis G; Tzartos JS; Velonakis G; Evangelopoulos ME; Tzanetakos D; Karagiorgou K; Angelopoulou G; Kasselimis D; Potagas C; Anagnostouli M; Stefanis L; Kilidireas C
Mult Scler Relat Disord; 2019 Aug; 33():67-69. PubMed ID: 31158804
[TBL] [Abstract][Full Text] [Related]
32. Alpha actinin is specifically recognized by Multiple Sclerosis autoantibodies isolated using an N-glucosylated peptide epitope.
Pandey S; Dioni I; Lambardi D; Real-Fernandez F; Peroni E; Pacini G; Lolli F; Seraglia R; Papini AM; Rovero P
Mol Cell Proteomics; 2013 Feb; 12(2):277-82. PubMed ID: 23139387
[TBL] [Abstract][Full Text] [Related]
33. Targets of the humoral autoimmune response in multiple sclerosis.
Fraussen J; Claes N; de Bock L; Somers V
Autoimmun Rev; 2014 Nov; 13(11):1126-37. PubMed ID: 25108168
[TBL] [Abstract][Full Text] [Related]
34. The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis.
van Noort JM; van Sechel AC; Bajramovic JJ; el Ouagmiri M; Polman CH; Lassmann H; Ravid R
Nature; 1995 Jun; 375(6534):798-801. PubMed ID: 7596414
[TBL] [Abstract][Full Text] [Related]
35. HLA restriction and TCR usage of T lymphocytes specific for a novel candidate autoantigen, X2 MBP, in multiple sclerosis.
Voskuhl RR; Robinson ED; Segal BM; Tranquill L; Camphausen K; Albert PS; Richert JR; McFarland HF
J Immunol; 1994 Nov; 153(10):4834-44. PubMed ID: 7525716
[TBL] [Abstract][Full Text] [Related]
36. Epitope spreading as an early pathogenic event in pediatric multiple sclerosis.
Quintana FJ; Patel B; Yeste A; Nyirenda M; Kenison J; Rahbari R; Fetco D; Hussain M; O'Mahony J; Magalhaes S; McGowan M; Johnson T; Rajasekharan S; Narayanan S; Arnold DL; Weiner HL; Banwell B; Bar-Or A;
Neurology; 2014 Dec; 83(24):2219-26. PubMed ID: 25381299
[TBL] [Abstract][Full Text] [Related]
37. Intrathecal CD4(+) and CD8(+) T-cell responses to endogenously synthesized candidate disease-associated human autoantigens in multiple sclerosis patients.
van Nierop GP; Janssen M; Mitterreiter JG; van de Vijver DA; de Swart RL; Haagmans BL; Verjans GM; Hintzen RQ
Eur J Immunol; 2016 Feb; 46(2):347-53. PubMed ID: 26507805
[TBL] [Abstract][Full Text] [Related]
38. Multiple sclerosis. Presenting an odd autoantigen.
Steinman L
Nature; 1995 Jun; 375(6534):739-40. PubMed ID: 7541112
[No Abstract] [Full Text] [Related]
39. Lipid autoreactivity in multiple sclerosis.
Blewett MM
Med Hypotheses; 2010 Mar; 74(3):433-42. PubMed ID: 19932569
[TBL] [Abstract][Full Text] [Related]
40. Bullous pemphigoid antigen 1 isoforms: potential new target autoantigens in multiple sclerosis?
Laffitte E; Burkhard PR; Fontao L; Jaunin F; Saurat JH; Chofflon M; Borradori L
Br J Dermatol; 2005 Mar; 152(3):537-40. PubMed ID: 15787824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
